By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel is divided on ARLO and EVLV's AI subscription pivot. While bulls see recurring revenue growth and margin expansion, bears caution about hardware exposure, customer concentration, detection accuracy, and regulatory risks.
Risk: Detection accuracy and potential liability events, especially for EVLV in high-stakes venues.
Opportunity: Recurring revenue growth and margin expansion through AI-enabled software subscriptions.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Arlo isn’t really selling cameras anymore -- it's turning AI-powered security software into a recurring revenue platform.
Evolv's biggest bullish signal may not be its recent deals with stadium owners, but the fact that so many of its established customers kept renewing even after the company came under regulatory scrutiny.
I used to think the biggest opportunities in tech were hiding inside flashy artificial intelligence (AI) models or chip companies. I've spent a lot of time over the last couple of years chasing beaten-down big-name stocks, but sometimes the more interesting story is a business quietly transforming its products and subscription model right under Wall Street's nose -- and both Arlo Technologies (NYSE: ARLO) and Evolv Technologies (NASDAQ: EVLV) look like companies the market still fundamentally misunderstands.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
This is the part Wall Street keeps getting wrong about Arlo Technologies: It still prices the stock like a consumer hardware business, even as the company has spent the last two years systematically converting itself into a pure software and services platform.
The camera hardware still exists, but it's increasingly just the vehicle that gets subscribers into Arlo's ecosystem. The real product is Arlo Intelligence -- a suite of AI features baked into the subscription platform that handles everything from package detection and person recognition to proactive security alerts that the company describes as moving beyond passive recording into automated, real-time response. Arlo isn't just storing video anymore. It's interpreting what's happening in front of the camera and deciding what matters.
What changed the story for me is the partnership strategy. In January, Arlo extended its relationship with Samsung in a service-only arrangement -- no hardware required -- to power smart security features inside Samsung SmartThings for millions of connected home users. That's a clean departure from selling cameras. It's licensing AI software to one of the world's largest consumer electronics platforms.
The market is still sitting on its hands. Some fair-value estimates on Arlo sit at $24 against a current price of around $13.50. Analysts covering the stock have an average price target of $22. The stock is down on a one-month basis, even as the business has turned profitable and annual recurring revenue is growing at a 28% clip. That's a gap between what the business is doing and what the market is crediting it for -- and such gaps tend to close over time.
Evolv Technologies (NASDAQ: EVLV) makes AI-powered weapons detection systems. Not drones or security towers, but scanners that use machine learning to identify concealed guns and knives without requiring people to stop, empty their pockets, or wait in slow security lines. Every major sports venue, arena, or school that replaces traditional security technology and metal detectors with Evolv's system is signing a subscription contract that is likely to be renewed and expanded over time.
The company has been stacking those contracts, and its pace hasn't slowed. In March, the Houston Astros renewed and expanded their partnership with Evolv to cover all fan entry points at Minute Maid Park. In April, Crypto.com Arena -- home of the NBA's Los Angeles Lakers and the NHL's Los Angeles Kings -- renewed and expanded its multiyear partnership. Later that month, Evolv reached 50% market share across all North American professional soccer venues after adding the Philadelphia Union to its roster. This is a pattern of the same customers coming back and asking for more.
The professional sports use case gets the headlines, but the deployment that I think is most underappreciated is in educational settings. In 2025, after Evolv reached a settlement with the Federal Trade Commission over what the regulator asserted were deceptive marketing claims, there was a window for some of the company's school customers to cancel their contracts -- but 92% of eligible K-12 customers chose to stay. That retention number, coming immediately after a regulatory challenge, tells you more about the product's actual value to customers than any press release would.
In my opinion, Wall Street is treating Evolv like a speculative security start-up that still needs to prove its model. However, the company's recurring contract structure, its retention rate, and its expansion pattern across professional sports, entertainment, and education suggest the model is proven. To me, that's the definition of a discount worth buying.
Before you buy stock in Evolv Technologies, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Evolv Technologies wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $471,072! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,303,352!
Now, it’s worth noting Stock Advisor’s total average return is 983% — a market-crushing outperformance compared to 210% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of May 28, 2026. *
Micah Zimmerman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Arlo Technologies and Evolv Technologies. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"EVLV's high retention post-FTC scrutiny does not offset risks of revenue concentration and recurring regulatory exposure that justify the current discount."
The article frames ARLO's pivot to AI subscription licensing and EVLV's post-FTC retention as clear mispricings, yet both still carry material hardware exposure and customer concentration risks that the bullish narrative downplays. ARLO's Samsung deal is service-only but its core camera base remains tied to consumer hardware cycles, while EVLV's 92% school renewals came after a settlement that could recur. At 28% ARR growth for ARLO and venue expansions for EVLV, multiples near 13-14x forward sales look cheap only if churn stays negligible and no larger security incumbents replicate the AI detection layer. Execution on pure software margins remains unproven at scale.
The regulatory settlement and hardware mix may prove one-time noise rather than structural flaws, allowing the recurring revenue model to compound faster than peers if venue and education pipelines hold.
"Both companies show genuine business model shifts and retention strength, but the article overstates how 'wrong' Wall Street is without addressing whether current valuations already price in the subscription thesis or whether hardware/regulatory headwinds will constrain margin expansion."
The article conflates two distinct narratives. Arlo's 28% ARR growth is real, but the Samsung deal is a licensing arrangement, not proof of a SaaS transformation—hardware still drives unit economics. Evolv's 92% K-12 retention post-FTC settlement is genuinely impressive, but the article cherry-picks venue renewals without addressing TAM constraints or competitive threats from legacy security vendors pivoting to AI. Both stocks are cheap relative to growth, but 'Wall Street has it wrong' is doing heavy lifting here. The real question: are these subscription conversions durable, or are they early-cycle tailwinds masking margin pressure?
Arlo's hardware dependency remains structural—Samsung licensing likely generates lower margins than direct subscriptions, and the 28% ARR growth rate may already be baked into a $13.50 stock trading below analyst targets. Evolv's 92% retention is post-settlement noise; the FTC challenge itself signals product or marketing credibility issues that could resurface.
"The market is not mispricing these stocks out of ignorance, but rather pricing in the significant execution and liability risks inherent in their respective pivot strategies."
Arlo (ARLO) and Evolv (EVLV) are classic 'pivot' plays, but the market's skepticism is earned, not just a misunderstanding. Arlo’s transition to SaaS is impressive, yet they remain tethered to the commoditized smart-home camera market where margins are easily pressured by Big Tech incumbents like Amazon’s Ring or Google’s Nest. Evolv, meanwhile, faces a massive 'tail risk' regarding efficacy. The FTC scrutiny mentioned is a red flag, not a badge of honor; if a single high-profile security failure occurs, their reputation-based business model could collapse overnight. While the recurring revenue metrics are attractive, both companies are currently priced for perfection in sectors where 'good enough' hardware often beats 'premium' AI software.
The bull case ignores that both companies operate in high-liability, low-moat environments where a single regulatory or technical failure could trigger a catastrophic loss of institutional trust.
"Durable recurring revenue from AI-enabled software could unlock upside for ARLO and EVLV, but upside hinges on regulatory stability, continued renewals, and scalable unit economics."
From ARLO and EVLV's vantage, the story isn't hardware but recurring revenue from AI-enabled software. Arlo's pivot to subscription AI (Arlo Intelligence) and Samsung SmartThings licensing could lift margins and embed the product in large ecosystems, while Evolv's retention after an FTC settlement and multi-year venue deals hints at a durable moat. Yet I worry about the bear case: the upside rests on customers renewing and adopting AI features at scale, which could take longer than investors expect; regulatory winds and privacy concerns could reappear; and both names trade as small-cap AI plays where hype can outpace unit economics.
The strongest countercase is that AI-based monetization for security remains nascent; execution risk could undercut margins, renewals could lag in a cost-cutting cycle, and any regulatory tightening or privacy backlash could crater the assumed moat.
"ARLO and EVLV share undetected regulatory spillover risks that could compress multiples beyond current hardware concerns."
Gemini overstates the 'priced for perfection' label when ARLO sits at 13-14x sales with hardware still dominant. The missing risk is cross-contamination: if Evolv's AI false positives trigger liability in venues, as the FTC case hinted, it could spill over to ARLO's subscription credibility in education and enterprise. Both hinge on flawless detection that legacy vendors can challenge without similar regulatory scars.
"EVLV's FTC settlement is closure, not a liability template; the real risk is both companies need detection accuracy neither has demonstrated at enterprise scale."
Grok's cross-contamination risk is real but inverted. ARLO's subscription margins depend on detection accuracy; EVLV's FTC settlement actually signals regulatory *resolution*, not ongoing liability. The spillover risk cuts the other way: if ARLO's AI false positives trigger education liability, it validates EVLV's prior scrutiny without solving either company's core problem—both need flawless detection at scale, which neither has proven. That's the shared structural risk, not regulatory contagion.
"Evolv faces existential binary risk from detection failure that Arlo's consumer-focused model does not share."
Claude, you’re missing the fundamental difference in revenue quality. Arlo’s subscription model is B2C-led, where false positives are a nuisance; Evolv’s is B2B, where they are a liability event. Gemini is right to fear the 'reputation-based' collapse. If Evolv’s detection fails in a high-stakes venue, the contract isn't just cancelled—it's a legal catastrophe. Arlo’s 'pivot' is a margin expansion story, but Evolv is a binary bet on product efficacy that the market is severely underpricing.
"Evolv's 'binary' bet on product efficacy overlooks ongoing costs and regulatory risk that could erode margins and renewals."
Gemini, you're right that Evolv's moat rests on detection efficacy, but you're missing the cost and regulatory path to scale. The big risk isn't a single false positive; it's ongoing false‑positive costs and liability exposure that could trigger contract penalties or early terminations in sensitive venues, plus potential future privacy/AI regs that compress margins. If the system demands constant calibration and data-sharing across many venue types, the 'binary' bet becomes a multi‑year margin compression story, not a slam dunk.
The panel is divided on ARLO and EVLV's AI subscription pivot. While bulls see recurring revenue growth and margin expansion, bears caution about hardware exposure, customer concentration, detection accuracy, and regulatory risks.
Recurring revenue growth and margin expansion through AI-enabled software subscriptions.
Detection accuracy and potential liability events, especially for EVLV in high-stakes venues.